Michael Donoviel

Michael Donoviel is a seasoned professional in the biopharmaceutical industry, specializing in medical science liaison roles and medical directorships. Currently serving as a Senior Medical Science Liaison at Apellis Pharmaceuticals since September 2024, Michael previously held a similar position at Alpine Immune Sciences, Inc. where leadership was provided for povetacicept in hematology and support for nephrology clinical trials. Prior experience includes serving as Medical Director for Dermatology & Rare Diseases at Priovant Therapeutics and as a Principal MSL at Arena Pharmaceuticals. Michael's career also includes significant roles at Mallinckrodt Pharmaceuticals, IKARIA, Inc., and Lexicon Pharmaceuticals, where notable contributions to drug discovery and development were made. Michael's academic background includes a Ph.D. in Biochemistry and Molecular Biology from the University of Washington and a Bachelor's Degree in Biochemistry and Cell Biology from UC San Diego.